Oseltamivir
DrugBank ID: DB00198
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| influenza, severe, susceptibility to | 0.9872 | DL |
| pyelonephritis | 0.9785 | DL |
| disorder of tyrosine metabolism | 0.9669 | DL |
| teratogenic Pierre Robin syndrome | 0.9612 | DL |
| disorder of phenylalanine metabolism | 0.9574 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.9510 | DL |
| staphylococcus aureus infection | 0.9505 | DL |
| cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency | 0.9393 | DL |
| pneumonia | 0.9214 | DL |
| influenza | 0.9074 | DL |
| streptococcal pneumonia | 0.9046 | DL |
| aspergillosis, susceptibility to | 0.8978 | DL |
| dengue virus, susceptibility to | 0.8978 | DL |
| legionnaire disease, susceptibility to | 0.8978 | DL |
| susceptibility to HIV infection | 0.8978 | DL |
| Schistosoma mansoni infection, susceptibility | 0.8950 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.8890 | DL |
| hepatoportal sclerosis | 0.8890 | DL |
| hepatopulmonary syndrome | 0.8890 | DL |
| idiopathic copper-associated cirrhosis | 0.8890 | DL |
| primitive portal vein thrombosis | 0.8890 | DL |
| Plasmodium falciparum malaria | 0.8791 | DL |
| pyogenic bacterial infections due to MyD88 deficiency | 0.8698 | DL |
| hyperamylasemia | 0.8542 | DL |
| polyclonal hyperviscosity syndrome | 0.8542 | DL |
| Kaposi sarcoma, susceptibility to | 0.8538 | DL |
| Singleton-Merten syndrome | 0.8321 | DL |
| congenital analbuminemia | 0.8243 | DL |
| neonatal epileptic encephalopathy due to glutaminase deficiency | 0.8187 | DL |
| idiopathic bilateral vestibulopathy | 0.8146 | DL |
| semicircular canal dehiscence syndrome | 0.8146 | DL |
| blood group incompatibility | 0.8106 | DL |
| genetic otorhinolaryngological malformation | 0.8059 | DL |
| HHV-6 encephalitis | 0.8022 | DL |
| Hendra virus infection | 0.8022 | DL |
| acute necrotizing encephalitis | 0.8022 | DL |
| premalignant hematological system disease | 0.8003 | DL |
| hepatic porphyria | 0.8002 | DL |
| inborn disorder of phenylalanin or tyrosine metabolism | 0.7988 | DL |
| acute hemorrhagic encephalitis | 0.7970 | DL |
| pleural adenomatoid tumor | 0.7843 | DL |
| equine encephalitis | 0.7838 | DL |
| juvenile nasopharyngeal angiofibroma (disease) | 0.7815 | DL |
| monoclonal gammopathy | 0.7813 | DL |
| pleural biphasic mesothelioma | 0.7790 | DL |
| familial nasal acilia | 0.7769 | DL |
| tetrahydrobiopterin metabolic process disease | 0.7737 | DL |
| hematological disease associated with an acquired peripheral neuropathy | 0.7637 | DL |
| silent sinus syndrome | 0.7625 | DL |
| propylthiouracil embryofetopathy | 0.7625 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.